Target intelligence / Profile preview

ATP5MC2 pseudogene 4 (ATP5MC2P4)

Target
ATP5MC2P4
Molecular classification
Other (Pseudogene)
01

Overview

ATP5MC2 pseudogene 4 (ATP5MC2P4) is a pseudogene related to the ATP5MC2 gene, which encodes a subunit of the mitochondrial ATP synthase complex. Pseudogenes such as ATP5MC2P4 do not produce a functional protein product and do not have a direct biological function. ATP5MC2 is involved in the mitochondrial production of ATP during oxidative phosphorylation, but ATP5MC2P4 is a non-coding genomic element derived from duplication or retrotransposition events. There is no evidence that ATP5MC2P4 functions as a therapeutic target, encodes a receptor, enzyme, or transporter, or is directly involved in disease or drug interactions. The term "pseudogene" designates a gene sequence similar to a known gene but incapable of producing a functional protein, commonly due to disabling mutations or regulatory sequence changes. ATP5MC2P4 is not listed as a protein, receptor, enzyme, or recognized drug target in reference databases or the pharmacology literature. Sometimes there can be confusion between the pseudogene and its functional gene; the functional gene (ATP5MC2, also called ATP synthase membrane subunit c locus 2) plays a direct role in ATP production and mitochondrial energy metabolism. Pseudogenes such as ATP5MC2P4 are not known to be biomarkers, therapeutic targets, or associated with disease phenotypes. In summary: ATP5MC2 pseudogene 4 is a non-functional pseudogene, not a protein-coding therapeutic target, and is not associated with molecular function, disease, or drug interactions.

Other names
ATP5MC2P4ATP synthase membrane subunit c locus 2 pseudogene 4

Beyond the preview

Go deeper on ATP5MC2 pseudogene 4 (ATP5MC2P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP5MC2 pseudogene 4 (ATP5MC2P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call